| scholarly article | Q13442814 |
| P50 | author | Anirban Maitra | Q63019787 |
| Toby Cornish | Q57874316 | ||
| P2093 | author name string | Ming Zhao | |
| Robert A Anders | |||
| Balmiki Ray | |||
| Michelle A Rudek | |||
| Amarnath Maitra | |||
| Haibo Bai | |||
| Debomoy Lahiri | |||
| Savita Bisht | |||
| Masamichi Mizuma | |||
| Mehtab A Khan | |||
| Mena Bekhit | |||
| P2860 | cites work | Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor | Q24647242 |
| Bioavailability of curcumin: problems and promises | Q28257125 | ||
| Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells | Q28582231 | ||
| Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy | Q33282319 | ||
| Mechanisms of immune-mediated liver injury | Q33856306 | ||
| Hepatic fibrosis | Q33904174 | ||
| Curcumin: the Indian solid gold | Q34004696 | ||
| Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate | Q34167565 | ||
| Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine | Q34575185 | ||
| Relationship of oxygen and glutathione in protection against carbon tetrachloride-induced hepatic microsomal lipid peroxidation and covalent binding in the rat. Rationale for the use of hyperbaric oxygen to treat carbon tetrachloride ingestion | Q34621593 | ||
| Polymer conjugates: nanosized medicines for treating cancer | Q34651307 | ||
| Phase II trial of curcumin in patients with advanced pancreatic cancer | Q34796370 | ||
| Antidepressant activity of curcumin: involvement of serotonin and dopamine system | Q34819911 | ||
| Cancer risk and diet in India | Q35575541 | ||
| Innate immunity in the liver | Q36036373 | ||
| Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells | Q61763067 | ||
| Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis | Q62735118 | ||
| Contribution of the Lymphotoxin Receptor to Liver Regeneration | Q63968501 | ||
| Cytotoxic and cytoprotective activities of curcumin. Effects on paracetamol-induced cytotoxicity, lipid peroxidation and glutathione depletion in rat hepatocytes | Q68816787 | ||
| Collagen production by rat liver fat-storing cells in primary culture | Q68916661 | ||
| Anti-inflammatory activity of curcumin analogues | Q70452585 | ||
| Antihepatotoxic principles of Curcuma longa rhizomes | Q71153896 | ||
| Accumulation and cellular localization of fibrinogen/fibrin during shortterm and longterm rat liver injury | Q72114711 | ||
| Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells | Q73308051 | ||
| Protective effect of curcumin in rat liver injury induced by carbon tetrachloride | Q73797820 | ||
| Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice | Q81332054 | ||
| Targeted drug delivery in cancer therapy | Q36200150 | ||
| Multi-functional polymeric nanoparticles for tumour-targeted drug delivery | Q36409038 | ||
| Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration | Q36694655 | ||
| Mouse models of liver fibrosis | Q36712403 | ||
| Pharmacokinetics and pharmacodynamics of curcumin | Q36849531 | ||
| De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell (HSC) activation | Q36925890 | ||
| Innate immune response and hepatic inflammation | Q36989679 | ||
| Activation of peroxisome proliferator-activated receptor-gamma by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells | Q37170189 | ||
| Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride | Q37411006 | ||
| Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress | Q37456073 | ||
| Systemic delivery of curcumin: 21st century solutions for an ancient conundrum | Q37508096 | ||
| Mononuclear cells in liver fibrosis | Q37521983 | ||
| Hepatic lipocytes: the principal collagen-producing cells of normal rat liver | Q37558514 | ||
| Molecular pathogenesis of liver fibrosis | Q37600646 | ||
| Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts | Q37608238 | ||
| Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts | Q37825662 | ||
| An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. | Q38311930 | ||
| Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. | Q39677752 | ||
| In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities | Q39906054 | ||
| Molecular mechanisms of hepatic fibrosis and principles of therapy | Q40892757 | ||
| Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis | Q41055606 | ||
| Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages | Q41380057 | ||
| Peroxisome proliferator-activated receptors and hepatic stellate cell activation | Q41758990 | ||
| Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro | Q42808663 | ||
| Reduced glutathione protection against rat liver microsomal injury by carbon tetrachloride. Dependence on O2 | Q42865606 | ||
| Curcumin Enhances Oral Bioavailability and Anti-Tumor Therapeutic Efficacy of Paclitaxel upon Administration in Nanoemulsion Formulation | Q42906039 | ||
| Amelioration of hepatic fibrosis via Padma Hepaten is associated with altered natural killer T lymphocytes | Q43297664 | ||
| Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines | Q43486795 | ||
| Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth | Q44378715 | ||
| The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo | Q44383140 | ||
| Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences | Q45236793 | ||
| Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice | Q46370419 | ||
| The effects of curcumin on depressive-like behaviors in mice | Q46574916 | ||
| Structure-activity relationships for the inhibition of recombinant human cytochromes P450 by curcumin analogues | Q46772050 | ||
| Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation | Q46897681 | ||
| Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners | Q46939919 | ||
| Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. | Q46974412 | ||
| Biotransformation of curcumin through reduction and glucuronidation in mice | Q48249491 | ||
| Antioxidant activity of curcumin and related compounds | Q48373542 | ||
| Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. | Q50682895 | ||
| CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice. | Q52605857 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P921 | main subject | nanoparticle | Q61231 |
| curcumin | Q312266 | ||
| P304 | page(s) | 1383-1395 | |
| P577 | publication date | 2011-06-20 | |
| P1433 | published in | Laboratory Investigation | Q6467260 |
| P1476 | title | A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation | |
| P478 | volume | 91 |
| Q36234061 | A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy |
| Q38588143 | A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives |
| Q28384520 | Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public Health |
| Q48345993 | Attenuation of carbon tetrachloride-induced hepatic injury with curcumin-loaded solid lipid nanoparticles |
| Q36957725 | Cellular distribution of injected PLGA-nanoparticles in the liver |
| Q39046987 | Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin. |
| Q41785626 | Comparative Neuroprotective Effects of Dietary Curcumin and Solid Lipid Curcumin Particles in Cultured Mouse Neuroblastoma Cells after Exposure to Aβ42 |
| Q42710296 | Curcumin ameliorates intrahepatic angiogenesis and capillarization of the sinusoids in carbon tetrachloride-induced rat liver fibrosis |
| Q38072883 | Curcumin and liver disease. |
| Q46272793 | Curcumin attenuates high glucose-induced inflammatory injury through the reactive oxygen species-phosphoinositide 3-kinase/protein kinase B-nuclear factor-κB signaling pathway in rat thoracic aorta endothelial cells. |
| Q60958899 | Curcumin inhibits high glucose‑induced inflammatory injury in human retinal pigment epithelial cells through the ROS‑PI3K/AKT/mTOR signaling pathway |
| Q34658997 | Curcumin loaded NIPAAM/VP/PEG-A nanoparticles: physicochemical and chemopreventive properties. |
| Q41889295 | Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl₄-) induced liver injury in mice |
| Q42240679 | Effect of medicated serum of Curcumae Radix extract on mRNA expression of TIMP-1, MMPs-13 and aI-collagen of HSC-T6 cell |
| Q28551990 | Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model |
| Q36301960 | Efficacy of gold nanoparticles against isoproterenol induced acute myocardial infarction in adult male albino rats |
| Q92505179 | Encapsulated Curcumin Enhances Intestinal Absorption and Improves Hepatic Damage in Alcoholic Liver Disease-Induced Rats |
| Q47274086 | Enhanced efficacy of curcumin with phosphatidylserine-decorated nanoparticles in the treatment of hepatic fibrosis |
| Q34672342 | Functional characterization of a competitive peptide antagonist of p65 in human macrophage-like cells suggests therapeutic potential for chronic inflammation |
| Q36561567 | Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies |
| Q34414756 | Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats |
| Q37223485 | Inhibition of caspase-9 aggravates acute liver injury through suppression of cytoprotective autophagy. |
| Q36647007 | Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: Implications for breast cancer chemoprevention in at-risk popul |
| Q30374500 | Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response. |
| Q34349861 | Low-level laser therapy ameliorates CCl4-induced liver cirrhosis in rats. |
| Q95270262 | Nanocurcumin: A Promising Candidate for Therapeutic Applications |
| Q33780124 | Nanotechnology applications for the therapy of liver fibrosis |
| Q92980032 | Oral Delivery of Curcumin Polymeric Nanoparticles Ameliorates CCl₄-Induced Subacute Hepatotoxicity in Wistar Rats |
| Q38893647 | PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells. |
| Q39262135 | Pharmaceutical differences between block copolymer self-assembled and cross-linked nanoassemblies as carriers for tunable drug release |
| Q52587880 | Rdh13 deficiency weakens carbon tetrachloride-induced liver injury by regulating Spot14 and Cyp2e1 expression levels. |
| Q35174407 | Semi-quantitative monitoring of confluence of adherent mesenchymal stromal cells on calcium-phosphate granules by using widefield microscopy images |
| Q43542076 | Silymarin decreases connective tissue growth factor to improve liver fibrosis in rats treated with carbon tetrachloride |
| Q38473640 | Strategies to prevent and reverse liver fibrosis in humans and laboratory animals |
| Q36232513 | Therapeutic Applications of Curcumin Nanoformulations |
| Q27000074 | Therapeutic targeting of liver inflammation and fibrosis by nanomedicine |
| Q38073028 | Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies |
| Q89686706 | Vitis vinifera polyphenols from seedless black fruit act synergistically to suppress hepatotoxicity by targeting necroptosis and pro-fibrotic mediators |
Search more.